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EDITORIAL
Focus for John Yates III,
2004 ASMS Biemann Medal AwardeeIt is a pleasure to introduce in this issue a focus section
consisting of five articles honoring the achievements of
John R Yates III, Cell Biology Professor at the Scripps
Research Institute California. Over the past decade,
John’s research has been crucial in making the enor-
mous leap from genomics to proteomics, particularly in
relation to human disease. Specifically, his develop-
ment of the now benchmark technique affectionately
known as MudPIT (Multidimensional Protein Identifi-
cation Technology) has revolutionized proteomic anal-
ysis of biological assemblies in complex mixtures. Mud-
PIT is widely recognized as one of the most important
of the emerging MS systems, enabling detailed analyses
of the expression and function of the proteome and its
response to disease.
Among his many accolades, John has numerous
publications in Science, Nature and Cell. In 2002, he led a
collaboration of scientists from the USA and the UK to
determine the proteome of the most deadly form of the
malaria pathogen, identifying more than 2400 proteins.
Not only did he uncover those genes expressed at
different stages of the life cycle of P. falciparum, he also
determined which proteins are inside the cell and
which are membrane associated (Nature, October 3,
2002). This crucial information led directly to the iden-Published online June 23, 2005
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(J Am Soc Mass Spectrom 2005, 16, 1205–1206)tification of candidate antigens in the design and devel-
opment of potential vaccines. In other ground-breaking
research, John has employed subtractive proteomics to
more than quadruple the number of known lamina
proteins, and went on to identify 23 new nuclear
membrane proteins which map to chromosomal regions
linked to human dystrophies (Science, September 5,
2003).
John has inherited a flair for invention from his
one-time PhD supervisor and long-term mentor, D. F.
Hunt, whose article, “Electron Transfer Dissociation of
Peptide Anions” is published in the June issue. Where
established manufacturers have failed to meet his ex-
acting requirements, John has gone on to develop his
own innovative technology. By applying his imagina-
tion and intellect to fundamental biological questions,
John has produced reams of new information and a
remarkable variety of potential candidates for the fu-
ture treatment of human diseases.
The theme of human disease and its elucidation by
MS techniques such as MudPIT is continued in the first
of our dedicated articles. A. Emili and his colleagues
present an analysis of complex tissue expression pat-
terns in normal and subcellular organelle fractions of
normal and diseased heart tissue. Employing an inge-
nious adaptation of subcellular fractionation to isolate
r Inc.
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group has highlighted, and successfully overcome,
many of the challenges presented by this fibrous tissue.
In addition, the technical and computational solutions
offered in this work make it an invaluable resource for
researchers involved in, or thinking of becoming in-
volved in, the MudPIT approach.
In a similar vein, the second of our dedicated papers
takes us a step closer to the goal of early disease
diagnosis by identifying protein species in biofluids
that are symptomatic of disease states. The wealth of
histopathological information contained in sera can
often be masked by contamination from proteins that
are abundant but not related to disease. T. D. Veenstra
and T. P. Conrads et al. present an ultrafiltration
methodology for the enrichment of low molecular
weight (LMW) serum proteome, to concomitantly iden-
tify and quantify putative biomarkers in a single, high-
throughput procedure. Combining MudPIT with differ-
ential labelling to examine trypsin-mediated
incorporation of 18O in the LMW serum proteome of
xenographed tumor-bearing mice, this group has dis-
tinguished over 6000 proteins, the largest number of
proteins identified in serum to date. Almost 30% of the
proteins identified by multiple fully tryptic peptides
displayed altered abundance in mice xenographed with
Lewis lung cancer. Of these, over 400 were quantita-
tively determined as having disrupted abundance in
relation to Lewis lung carcinoma. The methodology
presented by this group has wide ranging implications
for the quantitative analysis of protein species indica-
tive of human disease.
The use of protein biomarkers to detect the earliest
stages of disease by monitoring changes in protein
abundance is a theme picked up in the third of our
articles. J. Gao and collaborators present a set of recom-
mendations developed for the peptide hits technique
(PHT), a promising procedure for semi-quantitative
proteome screening. By refining and optimising the
necessary bioinformatics and statistical analyses for a
well defined sample, this group have opened up a
simple and rapid whole proteome screening technique
for the future analyses of unknown biomarker and/or
target discovery samples.
With the completion of each new genome comes the
further expansion of potential peptide sequences, and
the associated increase of ambiguity in peptide/protein
identification. In the fourth of our papers, R. D. Smith
and his co-workers present a theoretical study address-
ing the statistical challenges involved in unequivocal
identification of proteins from a progressively morecomplex pool. In silico tryptic digests of all predicted
proteins from the genomes of three organisms of vary-
ing complexity are evaluated by amalgamating accurate
mass with calculated LC normalized elution time
(NET). Their results show that where accurate mass
alone may leave room for doubt, in combination with
NET, a unique peptide fingerprint can be generated to
support peptide identification in the context of high-
throughput measurements. Importantly, this work
demonstrates the potential for employing NET in addi-
tion to accurate mass to evaluate proteomes of high
complexity whereby the majority of proteins should be
uniquely identifiable.
A large part of the remarkable progress witnessed in
MS in recent years is associated with the concurrent
increase in computer power and the development of
creative software to manage the staggering quantity of
information produced. A ubiquitous challenge in any
high-throughput approach such as shotgun proteomics
is that of spectral redundancy. This issue is addressed
by W. H. McDonald and colleagues in the last of our
dedicated articles. Here a novel algorithm,
MS2Grouper, is presented to elucidate structure in
proteomic data sets. Significant improvements to cur-
rent strategies are described to identify MS/MS spectra
which result from a single parent peptide. By autono-
mously detecting repetition of spectra, assessing related
spectral groups and then replacing these groups with
representative synthetic spectra, MS2Grouper cuts both
database search times and spectral noise without dimin-
ishing the number of peptides identified. Further, the
effect of false positive or negative results is largely
overcome by adopting a paraclique-based criterion for
assessing analogous spectra, which guards against er-
roneous similarity links. Importantly, this approach can
be adapted to run on arbitrarily large libraries of
spectra. By presenting data acquired from biologically
relevant samples, McDonald demonstrates the consid-
erable benefits MS2Grouper offers proteomics.
John R. Yates III was awarded the Pehr Edman
Award in 1998 and the American Society for Mass
Spectrometry Research award in 1996. In his meteoric,
but still youthful career, John’s work has become a
benchmark of excellence and in recognition of this he
truly is a very worthy recipient of the 2004 Biemann
Medal.
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